Added to YB: 2024-03-22
Pitch date: 2024-01-23
MEDP [bullish]
Medpace Holdings, Inc.
+47.94%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Market Cap
$10.5B
Pitch Price
$301.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.89
P/E
29.72
EV/Sales
4.84
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Next Century Growth Investors SMID Cap Growth Strategy New Portfolio holding: Medpace Holdings
MEDP: CRO for small & mid-sized biopharma. 75-80% small, 15-20% mid clients. Faster-growing market niche vs large pharma. Strong growth outlook from biotech spending & share gains. Healthy margins. Solid competitive position in target market.
Read full article (1 min)